Turnstone Biologics Corp (NASDAQ: TSBX) – Not A Clear Buying Opportunity?
Turnstone Biologics Corp (TSBX) concluded trading on Wednesday at a closing price of $0.57, with 6.9 million shares of worth about $3.93 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -82.46% during that period and on November 06, 2024 the price saw a […]
